BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8700151)

  • 1. Inhibition of receptor/G protein coupling by suramin analogues.
    Beindl W; Mitterauer T; Hohenegger M; Ijzerman AP; Nanoff C; Freissmuth M
    Mol Pharmacol; 1996 Aug; 50(2):415-23. PubMed ID: 8700151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suramin analogues as subtype-selective G protein inhibitors.
    Freissmuth M; Boehm S; Beindl W; Nickel P; Ijzerman AP; Hohenegger M; Nanoff C
    Mol Pharmacol; 1996 Apr; 49(4):602-11. PubMed ID: 8609887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential uncoupling of A1 adenosine and D2 dopamine receptors by suramin and didemethylated suramin (NF037).
    Waldhoer M; Bofill-Cardona E; Milligan G; Freissmuth M; Nanoff C
    Mol Pharmacol; 1998 May; 53(5):808-18. PubMed ID: 9584206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased inhibition by a suramin analogue of A1-adenosine receptor/G protein coupling in fused receptor/G protein tandems: the A1-adenosine receptor is predominantly coupled to Goalpha in human brain.
    Kudlacek O; Waldhoer M; Kassack MU; Nickel P; Salmi JI; Freissmuth M; Nanoff C
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):8-16. PubMed ID: 11862328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of bovine A1 adenosine receptors and G proteins in phospholipid vesicles: betagamma-subunit composition influences guanine nucleotide exchange and agonist binding.
    Figler RA; Lindorfer MA; Graber SG; Garrison JC; Linden J
    Biochemistry; 1997 Dec; 36(51):16288-99. PubMed ID: 9405064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
    Suzuki E; Kessler M; Montgomery K; Arai AC
    Mol Pharmacol; 2004 Dec; 66(6):1738-47. PubMed ID: 15448189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gsalpha-selective G protein antagonists.
    Hohenegger M; Waldhoer M; Beindl W; Böing B; Kreimeyer A; Nickel P; Nanoff C; Freissmuth M
    Proc Natl Acad Sci U S A; 1998 Jan; 95(1):346-51. PubMed ID: 9419378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogs.
    Hohenegger M; Matyash M; Poussu K; Herrmann-Frank A; Sarközi S; Lehmann-Horn F; Freissmuth M
    Mol Pharmacol; 1996 Dec; 50(6):1443-53. PubMed ID: 8967964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex.
    Nanoff C; Mitterauer T; Roka F; Hohenegger M; Freissmuth M
    Mol Pharmacol; 1995 Nov; 48(5):806-17. PubMed ID: 7476910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors.
    Soto F; Lambrecht G; Nickel P; Stühmer W; Busch AE
    Neuropharmacology; 1999 Jan; 38(1):141-9. PubMed ID: 10193905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin disrupts receptor-G protein coupling by blocking association of G protein alpha and betagamma subunits.
    Chung WC; Kermode JC
    J Pharmacol Exp Ther; 2005 Apr; 313(1):191-8. PubMed ID: 15626724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
    Kudlacek O; Just H; Korkhov VM; Vartian N; Klinger M; Pankevych H; Yang Q; Nanoff C; Freissmuth M; Boehm S
    Neuropsychopharmacology; 2003 Jul; 28(7):1317-27. PubMed ID: 12784121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups.
    Hausmann R; Rettinger J; Gerevich Z; Meis S; Kassack MU; Illes P; Lambrecht G; Schmalzing G
    Mol Pharmacol; 2006 Jun; 69(6):2058-67. PubMed ID: 16551782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of agonist responses at the A(1) adenosine receptor by an irreversible antagonist, receptor-G protein uncoupling and by the G protein activation state.
    Lorenzen A; Beukers MW; van der Graaf PH; Lang H; van Muijlwijk-Koezen J; de Groote M; Menge W; Schwabe U; IJzerman AP
    Biochem Pharmacol; 2002 Oct; 64(8):1251-65. PubMed ID: 12234606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.
    Ramkumar V; Stiles GL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1194-200. PubMed ID: 3138408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamically distinct high and low affinity states of the A(1) adenosine receptor induced by G protein coupling and guanine nucleotide ligation states of G proteins.
    Lorenzen A; Guerra L; Campi F; Lang H; Schwabe U; Borea PA
    Br J Pharmacol; 2000 Jun; 130(3):595-604. PubMed ID: 10821788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.
    Gazi L; Nickolls SA; Strange PG
    Br J Pharmacol; 2003 Mar; 138(5):775-86. PubMed ID: 12642378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein coupling of the rat A1-adenosine receptor--partial purification of a protein which stabilizes the receptor-G protein association.
    Nanoff C; Waldhoer M; Roka F; Freissmuth M
    Neuropharmacology; 1997 Sep; 36(9):1211-9. PubMed ID: 9364476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D2 dopamine receptor activation of potassium channels is selectively decoupled by Galpha-specific GoLoco motif peptides.
    Webb CK; McCudden CR; Willard FS; Kimple RJ; Siderovski DP; Oxford GS
    J Neurochem; 2005 Mar; 92(6):1408-18. PubMed ID: 15748159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.